1. Market Research
  2. > Biotechnology Market Trends
  3. > Biopharmaceutical

Biopharmaceutical Sector: Get Market Research and Figures

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
10 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Biopharmaceutical Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+1 646 893 5945

1-10 of about 1000 reports

Global Biopharmaceutical Industry - Forecast

  • January 2017
    15 pages
  • Biopharmaceutic...  

  • World  

    Asia  

View report >

Biopharmaceutical Industry in the US

  • June 2017
    70 pages
  • Biopharmaceutic...  

    R-and-D  

  • United States  

    North America  

View report >

Biopharmaceutical Industry in Ireland and Europe

  • February 2017
    16 pages
  • Biopharmaceutic...  

  • Ireland  

    Europe  

    World  

View report >

Biopharmaceutical Markets in Asia

  • January 2016
    8 pages
  • Biopharmaceutic...  

    Bioprocessing  

  • Asia  

View report >

Biopharmaceutical Industry in Japan

  • May 2016
    8 pages
  • Biopharmaceutic...  

  • Japan  

    United States  

    World  

View report >

Biopharmaceutical Industry in Germany

  • December 2016
    13 pages
  • Biopharmaceutic...  

  • Germany  

    Europe  

View report >

Biopharmaceutical Industry in the UK

  • January 2016
    60 pages
  • Biopharmaceutic...  

    Life Sciences  

  • United Kingdom  

    Europe  

View report >

Biopharmaceutical Industry in Canada - Forecast

  • November 2015
    19 pages
  • Biopharmaceutic...  

    Factor VIII  

  • Canada  

View report >

Biopharmaceutical Markets in Brazil - Forecast

  • May 2016
    5 pages
  • Biopharmaceutic...  

  • Brazil  

    China  

    South America  

View report >

Search in Biopharmaceutical Industry (About 1000 reports)
Parent industry: Biotechnology
Related industries: Biological Therapy, Biomaterial, Genetically Modified Organism, Genomics

About 300 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 1000 - $ 5995)

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • $ 5995
  • Industry report
  • August 2017
  • by GlobalData

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices Summary GlobalData’s new report, "United ...

Specialty Enzymes Market - Global Industry Analysis, Si ...

May 2017 $ 5795

Market Access Impact (us) [growth Hormone Deficiency]

June 2017 $ 5440

Market Access Impact (eu5) [growth Hormone Deficiency]

June 2017 $ 5440

Single-use Technologies For Biopharmaceuticals: Global ...

June 2017 $ 5501

Biopharmaceutical Cmo & Cro Market Analysis By Source, ...

July 2017 $ 4950

Aptamers Market Analysis By Types (nucleic Acid & Pepti ...

June 2017 $ 4950

Erythropoietin (epo) Drugs Market Analysis By Drug Clas ...

May 2017 $ 4950

Global Biosimilars Market

July 2017 $ 4250

Global Biopharmaceuticals Market

July 2017 $ 4250

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.